Bristol Myers Squibb Acquires Mirati Therapeutics for up to $5.8 Billion October 12, 2023 AutoBot News 0 Mirati’s focus on breakthrough cancer treatments will bolster Bristol Myers Squibb’s oncology portfolio.
